TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses

Journal Title: International Journal of Biomedical Science (IJBS) - Year 2008, Vol 4, Issue 4

Abstract

TP53 is the most common mutated gene in human cancers. Approximately half of all human malignancies exhibit TP53 mutations. The TP53 codon 72 polymorphism is a single-nucleotide polymorphism (SNP) in exon 4, resulting in the expression of either arginine (CGC) or proline (CCC) residues. In this article, we review literatures published in MEDLINE, and attempt to describe how these two polymorphic variants of TP53 are functionally distinct, and how they influence cancer vulnerability and response to chemotherapy. The Arg72 variant has been shown to be more likely to induce apoptosis than the Pro72 variant, due to its ability to localize itself to mitochondria and trigger the release of cytochrome c into the cytosol. However, but the influence of the PT53 codon 72 polymorphism on the risk of developing various cancers, and their progression remains inconclusive because there has been no sustained evidence supporting a crucial role for the codon 72 variant in cancer therapy till now. We hypothesize that TP53 might not only be involved in cell cycle control and the apoptosis induction response to DNA damage, but may also modulate individual cancer risk, and that this may correlate with the biofunctions of the two codon 72 variants. Additionally, latent factors might function synergistically with codon 72 variants to confer susceptibility to cancer development, progression, prognosis, and therapeutic responsiveness. Further etiological investigations are essential to reveal the association of and interaction between genetic and environmental factors in relation to carcinogenesis.

Authors and Affiliations

Hung-Yu Lin, Chun-Hsiung Huang, Wen-Jen Wu, Li-Ching Chang, For-Wey Lung

Keywords

Related Articles

Engineered FADD Induces Apoptosis via an Artificial Death-Inducing Signaling Complex (DISC)

An engineered Fas-associated death domain protein (FADD), 2DEDplusE—made previously by fusing the tandem DEDs of FADD to the E protein of lambda phage-greatly enhances apoptosis-inducing activity in adherent cells in vit...

Synthesis of Some New 3, 5-Bis (substituted) Pyrazoles and Isoxazoles Based on (N’1E, N’3E)- N’1, N’3-Bis (3, 4, 5-substitutedbenzlidene) Malonohydrazide under Solvothermal Conditions

Synthesis of pyrazole and isoxazole derivatives has been a subject of consistent interest because of the wide applications of such heterocycles in pharmaceutical as well as agrochemical industry. Numerous compounds conta...

TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses

TP53 is the most common mutated gene in human cancers. Approximately half of all human malignancies exhibit TP53 mutations. The TP53 codon 72 polymorphism is a single-nucleotide polymorphism (SNP) in exon 4, resulting in...

Relationship between NK Cell Activation and Clinical Response in Rheumatoid Arthritis Treated with Rituximab

Introduction: We investigated the relationship between the anti CD20 therapy and the NK cell phenotype in patients with Rheumatoid Arthritis (RA). Methods: patients with seropositive RA according to the ACR criteria tha...

Idiopathic Benign Hyper-CK-Emia

It is not uncommon for a rheumatologist to get a request for evaluating a patient with persistent elevation of serum creatine (phospho) kinase (CK) level (hyper-CK-emia) especially if this laboratory abnormality is persi...

Download PDF file
  • EP ID EP82953
  • DOI -
  • Views 122
  • Downloads 0

How To Cite

Hung-Yu Lin, Chun-Hsiung Huang, Wen-Jen Wu, Li-Ching Chang, For-Wey Lung (2008). TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses. International Journal of Biomedical Science (IJBS), 4(4), 248-254. https://www.europub.co.uk/articles/-A-82953